one ml of solution contains:
active substance: Olopatadine hydrochloride, equivalent to Olopatadine 1 mg,
Excipients: benzalkonium chloride, disodium phosphate hydrate, sodium chloride, hydrochloric acid 3.6% solution, sodium hydroxide 4% solution, water for injection.
For topical use: instill 1 drop twice daily into the lower conjunctival sac of the affected eye(s), in children over 3 years of age at the same dosage as in adults. If necessary, treatment can last up to four months. The duration of treatment is determined by the attending physician. In elderly people, patients with renal or hepatic insufficiency, no dose adjustment is required. In the case of combination therapy with other local eye medications, the interval between their use should be at least five minutes. Eye ointments should be applied last. To prevent contamination of the contents of the bottle, do not touch the tip of the pipette to your eyes or any other surface. Between uses, keep the bottle tightly closed.